The FDA has signaled that BPC-157 cannot be legally compounded under Section 503A or 503B
Studies demonstrate rapid systemic uptake and targeted activity at endothelial and fibroblastic levels, implicating it in nitric oxide modulation, collagen synthesis, and vascular repair
The wide deficiency prevalence range reported among vegans 5 to 52% in a 2024 Proceedings of the Nutrition Society study reflects the dramatic difference between those who supplement consistently and those who do not
Optimized volume/price ratio, extended autonomy (several weeks at typical 250-500 mcg dose), final concentration adjustable to protocol (5 mg/ml with 2 ml bacteriostatic, or 2.5 mg/ml with 4 ml for finer dosing)
Sermorelin was previously FDA-approved under the brand name Geref, both as a diagnostic agent for GH deficiency (Geref Diagnostic, approved 1997) and as a therapeutic agent for pediatric idiopathic GH deficiency